Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Journal of Neurology
|
May 6, 2025
Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID-19 task force of the European Academy of Neurology
Dániel Bereczki, Ádám Dénes, Filippo M Boneschi, et al.
European Journal of Neurology
|
December 1, 2023
The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics
Martin Rakusa, Elena Moro, Tamar Akhvlediani, et al.
European Journal of Neurology
|
April 27, 2024
The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future
Francesco Cavallieri, Johann Sellner, Tamar Akhvlediani, et al.
Acta Neurologica Belgica
|
March 15, 2018
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis
Guy Laureys, Barbara Willekens, Ludo Vanopdenbosch, et al.
Eclinicalmedicine
|
March 20, 2026
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosis
Margaux Poleur, Barbara Willekens, Bertrand Degos, et al.
Trials
|
January 28, 2014
Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial
Melissa Cambron, Jop Mostert, Patrick Haentjens, et al.
Journal of Neuroinflammation
|
August 17, 2019
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
Judith Derdelinckx, María José Mansilla, Maxime De Laere, et al.
Multiple Sclerosis and Related Disorders
|
December 20, 2025
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study
Helmut Butzkueven, Pamela Farr, Serkan Ozakbas, et al.
Neurology and Therapy
|
July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis
Mahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Journal of Neurology
|
April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study
Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Journal of Neurology
|
May 6, 2025
Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID-19 task force of the European Academy of Neurology
Dániel Bereczki, Ádám Dénes, Filippo M Boneschi, et al.
European Journal of Neurology
|
December 1, 2023
The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics
Martin Rakusa, Elena Moro, Tamar Akhvlediani, et al.
European Journal of Neurology
|
April 27, 2024
The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future
Francesco Cavallieri, Johann Sellner, Tamar Akhvlediani, et al.
Acta Neurologica Belgica
|
March 15, 2018
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis
Guy Laureys, Barbara Willekens, Ludo Vanopdenbosch, et al.
Eclinicalmedicine
|
March 20, 2026
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosis
Margaux Poleur, Barbara Willekens, Bertrand Degos, et al.
Trials
|
January 28, 2014
Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial
Melissa Cambron, Jop Mostert, Patrick Haentjens, et al.
Journal of Neuroinflammation
|
August 17, 2019
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
Judith Derdelinckx, María José Mansilla, Maxime De Laere, et al.
Multiple Sclerosis and Related Disorders
|
December 20, 2025
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study
Helmut Butzkueven, Pamela Farr, Serkan Ozakbas, et al.
Neurology and Therapy
|
July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis
Mahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Journal of Neurology
|
April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study
Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Page
of 8